Table 4 Characteristics among patients with Antiphospholipid Syndrome

Age, years

0.49

 < 40

36,441

47.54

9027

47.11

 40–60

16,662

21.74

4171

21.77

 > 60

23,549

30.72

5965

31.13

mean ± SD

42.71 ± 26.21

43.02 ± 26.45

0.15

Gender

0.82

 Female

45,015

58.73

11,237

58.64

 Male

31,637

41.27

7926

41.36

 Diabetes mellitus

323

0.42

3548

18.51

<.0001

 Hypertension

308

0.40

3632

18.95

<.0001

 Hyperlipidemia

267

0.35

2729

14.24

<.0001

 Stroke

285

0.37

4006

20.90

<.0001

 Heart failure

302

0.39

2646

13.81

<.0001

 Atrial fibrillation

313

0.41

411

2.14

<.0001

 Myocardial infarction

284

0.37

2197

11.46

<.0001

 PAOD

256

0.33

1879

9.81

<.0001

 Chronic kidney disease

324

0.42

3072

16.03

<.0001

 COPD

348

0.45

3672

19.16

<.0001

 Deep vein thrombosis

238

0.31

1167

6.09

<.0001

 Pulmonary embolism

284

0.37

410

2.14

<.0001

 Systemic lupus erythematosus

319

0.42

419

2.19

<.0001

 Rheumatoid arthritis

305

0.40

816

4.26

<.0001

 Systemic sclerosis

284

0.37

53

0.28

0.03

 Sjogren’s syndrome

26

0.03

498

2.6

<.0001

 Polymyositis & dermatomyositis

9

0.01

34

0.18

<.0001